Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.46 |
| ▸ | GLA | P06280 | 3/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | NQO2 | P16083 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 2/20 | 0.40 |
| ▸ | CASP7 | P55210 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | DRD1 | P21728 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL740017 | 0.97 | MAPT (0.53) | MAPTALDH1A1HPGDGLAACHE | |
| Iodide SCHEMBL1471059 | 0.97 | MAPT (0.53) | MAPTALDH1A1HPGDGLAACHE | |
| Hydrochloric Acid SCHEMBL31542018 | 0.97 | MAPT (0.53) | MAPTALDH1A1HPGDGLAACHE | |
| Water SCHEMBL1146714 | 0.95 | MAPT (0.50) | MAPTALDH1A1HPGDGLAACHE | |
| Iodide SCHEMBL1146708 | 0.92 | MAPT (0.48) | MAPTALDH1A1HPGDGLAACHE | |
| SCHEMBL3360974 | 0.86 | MAPT (0.42) | MAPTALDH1A1HPGDGLAACHE | |
| SCHEMBL8987972 | 0.84 | MAPT (0.40) | MAPTALDH1A1HPGDGLAACHE | |
| SCHEMBL12273001 | 0.81 | HTR3A (0.48) | MAPTALDH1A1HPGDGLAACHE | |
| Iodide SCHEMBL12813166 | 0.79 | HTR3A (0.47) | MAPTALDH1A1HPGDGLAACHE | |
| Trifluoroacetic Acid SCHEMBL2590381 | 0.78 | ALDH1A1 (0.38) | MAPTALDH1A1HPGDGLAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170275572-A1 | COMPOSITIONS FOR PHOTODYNAMIC CONTROL OF INFECTION | PUREPURGE, INC. (US) | 2017-09-28 | — | — | US | claimed |
| EP-3193864-A1 | COMPOSITIONS FOR PHOTODYNAMIC CONTROL OF INFECTION | Purepurge, Inc. (US) | 2017-07-26 | — | — | EP | claimed |
| EP-3055291-A1 | METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC) | WisTa Laboratories Ltd. (SG) | 2016-08-17 | — | — | EP | claimed |
| WO-2016039812-A1 | COMPOSITIONS FOR PHOTODYNAMIC CONTROL OF INFECTION | PUREPURGE, INC. (US) | 2016-03-17 | — | — | WO | claimed |
| WO-2015052496-A1 | METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC) | WISTA LABORATORIES LTD. (SG) | 2015-04-16 | — | — | WO | claimed |
| US-6966213-B2 | Rapid method for detecting leaks of hydraulic fluids in production plants | NALCO COMPANY (US) | 2005-11-22 | — | — | US | claimed |
| US-20050160795-A1 | Rapid method for detecting leaks of hydraulic fluids in production plants | ECOLAB USA INC. | 2005-07-28 | — | — | US | claimed |
| US-20010046662-A1 | Method of inactivating pathogens in a red blood cell-containing composition | THE AMERICAN NATIONAL RED CROSS | 2001-11-29 | — | — | US | claimed |
| WO-2001078792-A1 | METHOD OF INACTIVATING PATHOGENS | THE AMERICAN NATIONAL RED CROSS (US) | 2001-10-25 | — | — | WO | claimed |
| EP-0973383-A4 | INTRACELLULAR AND EXTRACELLULAR DECONTAMINATION OF WHOLE BLOOD AND BLOOD COMPONENTS BY AMPHIPHILIC PHENOTHIAZIN-5-IUM DYES PLUS LIGHT | AMERICAN NAT RED CROSS (US) | 2001-08-22 | — | — | EP | claimed |
| WO-2001049328-A1 | PHOTODYNAMIC INACTIVATION OF PATHOGENS IN BLOOD BY PHENOTHIAZINES AND OXYGEN | THE AMERICAN NATIONAL RED CROSS (US) | 2001-07-12 | — | — | WO | claimed |
| US-6030767-A | ADDING DYE TO WHOLE BLOOD OR BLOOD COMPONENTS SUCH AS ERYTHROCYTES OR PLASMA, THEN IRRADIATING WITH LIGHT OF AN APPROPRIATE INTENSITY AND WAVELENGTH FOR A SUFFICIENT TIME; FOR DEACTIVATING VIRUSES, BACTERIA, PARASITES AND LEUKOCYTES | THE AMERICAN NATIONAL RED CROSS (US) | 2000-02-29 | — | — | US | claimed |
| EP-0973383-A1 | INTRACELLULAR AND EXTRACELLULAR DECONTAMINATION OF WHOLE BLOOD AND BLOOD COMPONENTS BY AMPHIPHILIC PHENOTHIAZIN-5-IUM DYES PLUS LIGHT | THE AMERICAN NATIONAL RED CROSS (US) | 2000-01-26 | — | — | EP | claimed |
| WO-1998031219-A9 | INTRACELLULAR AND EXTRACELLULAR DECONTAMINATION OF WHOLE BLOOD AND BLOOD COMPONENTS BY AMPHIPHILIC PHENOTHIAZIN-5-IUM DYES PLUS LIGHT | — | 1998-12-17 | — | — | WO | claimed |
| WO-1998031219-A1 | INTRACELLULAR AND EXTRACELLULAR DECONTAMINATION OF WHOLE BLOOD AND BLOOD COMPONENTS BY AMPHIPHILIC PHENOTHIAZIN-5-IUM DYES PLUS LIGHT | THE AMERICAN NATIONAL RED CROSS (US) | 1998-07-23 | — | — | WO | claimed |
| US-5545516-A | LEUKODEPLETING TRANSFUSIBLE COMPOSITION, ADDING PHENOTHIAZINIUM DYE, IRRADIATING WITH LIGHT OF INTENSITY AND WAVELENGTHS TO BE ABSOBED BY DYE, INACTIVATING EXTRACELLULAR ENVELOPED VIRUSES PRESENT | THE AMERICAN NATIONAL RED CROSS (US) | 1996-08-13 | — | — | US | claimed |
| WO-1991016911-A1 | DECONTAMINATION OF WHOLE BLOOD AND CELLULAR COMPONENTS BY PHENTHIAZIN-5-IUM-DYES PLUS LIGHT | THE AMERICAN NATIONAL RED CROSS (US) | 1991-11-14 | — | — | WO | claimed |
| US-20260048066-A1 | TREATMENT OF NEURODEGENERATIVE DISORDERS UTILISING METHYLTHIONINIUM (MT)-CONTAINING COMPOUNDS | WISTA LABORATORIES LTD (SG) | 2026-02-19 | — | — | US | disclosed |
| WO-1991016911-A1 | DECONTAMINATION OF WHOLE BLOOD AND CELLULAR COMPONENTS BY PHENTHIAZIN-5-IUM-DYES PLUS LIGHT | THE AMERICAN NATIONAL RED CROSS (US) | 1991-11-14 | — | — | WO | disclosed |
| WO-1991016911-A1 | DECONTAMINATION OF WHOLE BLOOD AND CELLULAR COMPONENTS BY PHENTHIAZIN-5-IUM-DYES PLUS LIGHT | THE AMERICAN NATIONAL RED CROSS (US) | 1991-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048066-A1 | TREATMENT OF NEURODEGENERATIVE DISORDERS UTILISING METHYLTHIONINIUM (MT)-CONTAINING COMPOUNDS | MAPT, PARK7, TARDBP | MAPT 1/4885ALDH1A1 4715/4885HPGD 4355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.